Skip to main content
. 2011 Jan;2(1):56–64. doi: 10.1177/1947601911405044

Figure 3.

Figure 3.

Downregulation of β-catenin and induction of myeloid differentiation in the response of KU812 cells to GO-203 treatment. (A) KU812 cells were treated with 5 µM GO-203 or 5 µM CP-2 each day for 2 days. The GO-203–treated cells were also incubated in the presence of 5 mM NAC. Lysates were immunoblotted with the indicated antibodies. (B-D) KU812 cells were treated with 5 µM GO-203 or 5 µM CP-2 each day. Cells harvested at the indicated times were analyzed for expression of CD11b (B), CD11c (C), and CD14 (D). The results (mean ± SD of 3 determinations) are presented as the percentage of control (open bars), GO-203–treated (solid bars), and CP-2–treated (shaded bars) cells expressing the indicated markers.